Previous studies showed that Stat3 signaling or NAD+ metabolism can influence the function and recruitment of immunosuppressive cells within the tumor microenvironment.[26, 27] However, the mechanism of FK866 and C188‐9 combination therapy against immunosuppressive microenvironment is unknown. The gene discussed is STAT3; the disease is neoplasm.